Corbus Pharmaceuticals Inc.
CRBP | NASDAQ
$7.80
+$0.15 (+1.96%)
Sep 22, 2026, 1:07 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 97.32K | 136.56K | 647.82K |
Cost of Revenue | n/a | 49K | n/a | n/a | 100K | 15.64M | 146K | n/a | 200K | n/a | 147.98K | n/a | n/a | n/a | n/a | 374.8K | 370.38K | 368.45K | 375.15K | 8.32M | 11.27M | 10.72M |
Gross Profit | n/a | -49K | n/a | n/a | -100K | -15.64M | -146K | n/a | -200K | n/a | -147.98K | n/a | n/a | n/a | n/a | -374.8K | -370.38K | -368.45K | -375.15K | -8.22M | -11.13M | -10.07M |
Operating Income | n/a | -24.3M | -21.97M | -24.42M | -19.15M | -19.78M | -12.61M | -15.51M | -10.99M | -9.62M | -10.1M | -9.49M | -8.19M | -17.3M | -10.8M | -8.18M | -7.34M | -8.52M | -10M | -13.88M | -16.7M | -15.41M |
Interest Income | 1.16M | 1.4M | 1.41M | 1.13M | 1.31M | 1.68M | 3.55M | 1.19M | 906K | n/a | n/a | n/a | 232K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -35.04M | -22.97M | -20.56M | -23.34M | -17.66M | -16.98M | -9.53M | -13.78M | -10M | -6.9M | -8.02M | -10.05M | -8.78M | -17.74M | -10.88M | -8.78M | -13.25M | -9.44M | -10.26M | -2.18M | -17.14M | -16.07M |
Net Income | -35.04M | -22.97M | -20.56M | -23.34M | -17.66M | -16.98M | -9.53M | -13.78M | -10M | -6.9M | -8.02M | -10.05M | -8.78M | -17.74M | -10.88M | -8.78M | -13.25M | -9.44M | -10.26M | -2.18M | -17.14M | -16.07M |
Selling & General & Admin | 5.02M | 4.44M | 3.56M | 3.56M | 3.97M | 4.13M | 3.67M | 4.7M | 3.92M | 3.86M | 2.98M | 2.94M | 3.94M | 3.91M | 4.55M | 3.7M | 4.47M | 4.86M | 3.86M | 5.05M | 5.57M | 5.34M |
Research & Development | 31.18M | 19.82M | 18.41M | 20.86M | 15.19M | 15.64M | 8.79M | 10.81M | 6.87M | 5.76M | 6.98M | 6.55M | 4.25M | 13.39M | 6.24M | 4.11M | 2.5M | 3.29M | 5.76M | 8.7M | 11.27M | 10.72M |
Other Expenses | n/a | n/a | n/a | n/a | -100K | -15.64M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -8.09M | -11.27M | -10.72M |
Operating Expenses | 36.19M | 24.26M | 21.97M | 24.42M | 19.05M | 4.13M | 12.46M | 15.51M | 10.79M | 9.62M | 9.96M | 9.49M | 8.19M | 17.3M | 10.8M | 7.81M | 6.97M | 8.15M | 9.62M | 5.66M | 5.57M | 5.34M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 381K | 652K | 177.02K | 707.01K | 763.36K | 1.01M | 678.02K | 640.95K | 541.89K | 490.34K | 458.91K | 390.9K | 391.87K | 401.17K | 646.55K |
Selling & Marketing Expenses | n/a | -49K | n/a | n/a | n/a | n/a | n/a | n/a | -200K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | n/a | 24.3M | 21.97M | 24.42M | 19.15M | 19.78M | 12.61M | 15.51M | 10.99M | 9.62M | 10.1M | 9.49M | 8.19M | 17.3M | 10.8M | 8.18M | 7.34M | 8.52M | 10M | 13.97M | 16.84M | 16.06M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 19.41M | 13.32M | 13.32M | 12.31M | 12.24M | 12.2M | 12.18M | 12.01M | 2.81M | 2.81M | 4.42M | 4.42M | 4.28M | 4.18M | 4.17M | 4.17M | 4.17M | 4.17M | 4.17M | 4.17M | 3.88M | 3.88M |
Shares Outstanding (Diluted) | 19.41M | 13.32M | 13.32M | 12.31M | 12.24M | 12.2M | 12.18M | 12.01M | 2.81M | 2.81M | 4.42M | 4.42M | 4.28M | 4.18M | 4.17M | 4.18M | 4.18M | 4.17M | 4.17M | 4.17M | 3.88M | 3.88M |
EPS (Basic) | -1.81 | -1.72 | -1.54 | -1.90 | -1.44 | -1.39 | -0.78 | -1.15 | -3.55 | -2.45 | -1.81 | -2.27 | -2.05 | -4.24 | -2.61 | -2.11 | -3.18 | -2.26 | -2.46 | -0.52 | -4.42 | -4.14 |
EPS (Diluted) | -1.81 | -1.72 | -1.54 | -1.90 | -1.44 | -1.39 | -0.78 | -1.15 | -3.55 | -2.45 | -1.81 | -2.27 | -2.05 | -4.24 | -2.61 | -2.10 | -3.17 | -2.26 | -2.46 | -0.52 | -4.42 | -4.14 |
EBITDA | n/a | -22.92M | -20.51M | -23.29M | -17.56M | -18.58M | -9.38M | -13.25M | -9.15M | -5.91M | -7.17M | -8.92M | -7.62M | -16.88M | -9.86M | -7.87M | -12.39M | -8.61M | -9.49M | -13.01M | -16.47M | -15.14M |
EBIT | n/a | -22.97M | -20.56M | -23.34M | -17.66M | -18.66M | -9.53M | -13.4M | -9.35M | -6.06M | -7.31M | -9.07M | -7.78M | -17.07M | -10.24M | -8.24M | -12.76M | -8.98M | -9.87M | -13.27M | -16.74M | -15.41M |
Depreciation & Amortization | n/a | 49K | 49K | 50K | 100K | 81K | 146K | 152K | 200K | 152K | 147.98K | 153K | 158.13K | 181.87K | 374.22K | 374.8K | 370.38K | 368.45K | 375.15K | 256.29K | 263.66K | 272.19K |
Add to Watchlist
Select watchlists to add or remove CRBP